Not supported media playback on the device

AstraZeneca to develop new drugs to combat chronic diseases

January 29, 2015 at 10:26 GMT Last Updated

The pharmaceutical company AstraZeneca, a research program to develop a new generation of drugs for the treatment of genetic causes of many serious diseases such as diabetes, heart disease and many cancers.

Since 2000, he had high hopes for the Human Genome Project after the discovery of the gene decoding, but 15 years of great progress that has been.

The company has grown to be connected with the Wellcome Trust Sanger Institute in order to "cut" to develop new drugs with a new technique called CRISPR the specific disease genes for drug discovery.

Pallab Ghosh reports.